Pulmonary embolism due to internal jugular vein thrombosis in a patient with non-small cell lung cancer receiving bevacizumab

Yosuke Togashi, Young Hak Kim, Katsuhiro Masago, Koji Tamai, Yuichi Sakamori, Tadashi Mio, Michiaki Mishima

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Internal jugular vein thrombosis is much less common than deep venous thrombosis of lower limbs and is generally caused by an indwelling venous catheter or otological infection. Several cases of internal jugular vein thrombosis associated with malignancy have been also reported. Bevacizumab, a monoclonal neutralizing antibody against vascular endothelial growth factor, has shown benefits in the treatment of many types of malignancy and its use is increasing. Serious adverse effects, however, are associated with the use of bevacizumab, including venous thromboembolism. In this article, we present a rare case of non-small cell lung cancer complicated by pulmonary embolism due to internal jugular vein thrombosis associated with bevacizumab.

Original languageEnglish
Pages (from-to)444-446
Number of pages3
JournalInternational Journal of Clinical Oncology
Volume16
Issue number4
DOIs
Publication statusPublished - Aug 2011
Externally publishedYes

Keywords

  • Bevacizumab
  • Internal jugular vein thrombosis
  • Non-small-cell lung cancer
  • Pulmonary embolism

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Pulmonary embolism due to internal jugular vein thrombosis in a patient with non-small cell lung cancer receiving bevacizumab'. Together they form a unique fingerprint.

Cite this